Source:http://linkedlifedata.com/resource/pubmed/id/12542493
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-1-24
|
pubmed:abstractText |
Thromboembolic disorders are common in cancer patients. Two major contributing factors are central venous catheters for drug delivery and the use of l-aparaginase, which decreases the plasma antithrombin level, but the causes of the hypercoagulable state in these patients are not fully understood. In this study, the T24/83 cell line was used as a model to investigate the effects of chemotherapeutic agents on cell surface thrombin regulation. Plasma thrombin generation and prothrombin consumption was increased in most of the treated cells, particularly vincristine- and adriamycin-treated cells (P < 0.05), compared with controls. However, no free thrombin generation or prothrombin consumption was observed in factor VII (FVII)-depleted plasma. No significant differences in the levels of thrombin-alpha2-macroglobulin (IIa-alpha2M) and thrombin-anti-thrombin (TAT) were observed between controls and any of the treatments, except for vincristine- and adriamycin-treated cells, which showed a significant difference in TAT production (P < 0.05). Also, there was an upregulation in tissue factor (TF) mRNA expression in etoposide-, methotrexate- and vincristine-treated monolayers compared with controls, as well as an upregulation in TF protein production in vincristine-treated cells. The data suggests that thrombin generation occurs via the extrinsic (TF-dependent) coagulation pathway on cell surfaces and that some chemotherapeutic agents are able to upregulate TF mRNA and protein expression in T24/83 cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antithrombins,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboplastin,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Macroglobulins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
315-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12542493-Antineoplastic Agents,
pubmed-meshheading:12542493-Antithrombins,
pubmed-meshheading:12542493-Cell Membrane,
pubmed-meshheading:12542493-Doxorubicin,
pubmed-meshheading:12542493-Etoposide,
pubmed-meshheading:12542493-Humans,
pubmed-meshheading:12542493-Methotrexate,
pubmed-meshheading:12542493-Prothrombin,
pubmed-meshheading:12542493-Thrombin,
pubmed-meshheading:12542493-Thromboplastin,
pubmed-meshheading:12542493-Thrombosis,
pubmed-meshheading:12542493-Tumor Cells, Cultured,
pubmed-meshheading:12542493-Urinary Bladder Neoplasms,
pubmed-meshheading:12542493-Vincristine,
pubmed-meshheading:12542493-alpha-Macroglobulins
|
pubmed:year |
2003
|
pubmed:articleTitle |
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.
|
pubmed:affiliation |
Henderson Research Centre, Hamilton, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|